NL-OMON33547已完成3 期
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106 - Extension trial of protocol 21106
Schering-Plough0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •sign written informed consent
- •completed trial 21106 (i.e. completed 26 weeks of treatment and finished the 7-day discontinuation period)
排除标准
- •any (serious) adverse event, medical condition or required concomitant medication deemed relevant for exclusion in trial 21106, as judged by the investigator
- •were significantly non compliant with protocol criteria and procedures of trial 21106, as judged by the investigator
研究者
相似试验
进行中（未招募）
1 期
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. - AquamarineEUCTR2007-005237-10-FRV Organon211
进行中（未招募）
1 期
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. - AquamarinePrimary insomniaMedDRA version: 9.1Level: LLTClassification code 10036701Term: Primary insomniaEUCTR2007-005237-10-HUV Organon211
进行中（未招募）
1 期
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. - AquamarineEUCTR2007-005237-10-GBV Organon211
进行中（未招募）
不适用
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. - AquamarineEUCTR2007-005237-10-DEV Organon211
进行中（未招募）
不适用
A twenty-six weeks, open-label extension trial to evaluate safety and efficacy of Org 50081 in outpatients with chronic primary insomnia who completed clinical trial protocol 21106. - AquamarinePrimary insomniaMedDRA version: 9.1Level: LLTClassification code 10036701Term: Primary insomniaEUCTR2007-005237-10-SEV Organon211